tiprankstipranks
Biofrontera Ag (BFAGY)
OTHER OTC:BFAGY

Biofrontera Ag Stock Analysis & Ratings

BFAGY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.09 - $6.89
Previous Close$2.39
Volume629.00
Average Volume (3M)39.12K
Market CapN/A
Enterprise ValueN/A
P/E Ratio3.9
Beta3.19
Next EarningsSep 01, 2022
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

BFAGY FAQ

What was Biofrontera Ag’s price range in the past 12 months?
Biofrontera Ag lowest stock price was $2.09 and its highest was $6.89 in the past 12 months.
    What is Biofrontera Ag’s market cap?
    Currently, no data Available
    What is Biofrontera Ag’s price target?
    Currently, no data Available
    What do analysts say about Biofrontera Ag?
    Not enough analysts have published a price target to provide an average price target.
    When is Biofrontera Ag’s upcoming earnings report date?
    Biofrontera Ag’s upcoming earnings report date is Sep 01, 2022 which is in 59 days.
      How were Biofrontera Ag’s earnings last quarter?
      Currently, no data Available
      Is Biofrontera Ag overvalued?
      According to Wall Street analysts Biofrontera Ag’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Biofrontera Ag pay dividends?
        Biofrontera Ag pays a Semiannually dividend of $0.1 which represents an annual dividend yield of N/A. Biofrontera Ag’s last Semiannually dividend payment was on Mar 04, 2021. Biofrontera Ag’s upcoming ex-dividend date is Feb 24, 2021
          What is Biofrontera Ag’s EPS estimate?
          Biofrontera Ag’s EPS estimate is -$0.22.
            How many shares outstanding does Biofrontera Ag have?
            Biofrontera Ag has 28,358,692 shares outstanding.
              What happened to Biofrontera Ag’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Biofrontera Ag?
              Currently, no hedge funds are holding shares in BFAGY

              ---

              Biofrontera Ag Stock Analysis

              Smart Score
              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              Price Target
              No data currently available
              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              Biofrontera Ag

              Biofrontera AG operates as a biopharmaceutical company, which engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.

              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Erytech Pharma SA
              Autolus Therapeutics
              Eyenovia
              Beyondspring
              Scholar Rock Holding

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis